Email
Print
Selected Reaction Monitoring Market - Forecast(2024 - 2030)
Selected Reaction Monitoring Market Overview
Selected Reaction Monitoring Market size is estimated at $456 million in 2020, projected to grow at a CAGR of 5.2% during the forecast period 2021-2026. Selected reaction monitoring (SRM) Assay is a targeted mass spectrometry technique that is emerging as a complement to untargeted shotgun methods in the field of targeted proteomics. When predetermined sets of proteins that make up cellular networks or sets of candidate biomarkers, need to be calculated through several samples in a standardized, repeatable, and quantitatively precise manner, SRM comes in handy. Instead of going through large quantities of data from non- targeted proteomics experiments, the SRM platform technology allows for selective filtering of particular proteins. This effective method for measuring targeted proteomics proteins quantitatively has become a standard tool in research methodologies today.
Selected Reaction Monitoring are commonly used in research institutes and diagnostic centres to measure biological markers in biological samples or to track disease and treatment progress. Selected Reaction Monitoring work best for peptides quantifications containing 7-17 amino acids. It is a more advanced treatment than conventional chemotherapy as it offers long-term cancer protection, has fewer side effects, and is effective against a wider range of cancer types and new-borns.
The growing use of Selected
Reaction Monitoring in research institutes, diagnostic centres, and hospitals is
driving growth in the Selected Reaction Monitoring industry. For the
quantification of protein and peptides quantification in a complex biological marker
sample, the Selected Reaction Monitoring method is a highly selective and
sensitive method. It employs mass spectroscopy to targeted proteomics and detects
the appropriate proteins, as well as to look for peptides quantifications and
protein fragments of interest.
Selected Reaction Monitoring Market Report Coverage
The report: “Selected Reaction Monitoring Market Forecast
(2021-2026)”, by Industry ARC, covers an in-depth analysis of the following
segments of the Selected Reaction Monitoring
Market.
By Type: Custom MRM
Assays, Human Discovery Assay, Human Cardiovascular MRM Assay and Human Cancer
MRM Assay.
By
Application: Biological Marker Assessment, MRM-MS Quality Control - Platform
Performance and Workflow Performance.
By End User: Hospitals, Diagnostic
Centres and Research Institutes.
By
Geography: North America
(U.S, Canada and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and
Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia &
New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina and
Rest of South America) and RoW (Middle East and Africa).
Key Takeaways
- Owing to the global pandemic, medical device manufacturers are concentrating on producing critical medical devices such as ventilators and diagnostics is expected to drive demand for Selected Reaction Monitoring.
- Geographically, North America Selected Reaction Monitoring Market held the largest revenue share of 42% in 2020 owing to the high investments in R&D and support of government investments in healthcare. In the final report, the scope of the Selected Reaction Monitoring Market for various regions will be given.
- The Selected Reaction Monitoring Industry is being driven by technological advances in oncology care on healthy tissues.
- Detailed analysis on the Strength, Weakness and Opportunities of
the prominent players operating in the market is provided in the Selected Reaction Monitoring Market.
Selected Reaction Monitoring Market: Market Share (%) by Region, 2020
For More Details on This Report - Request for Sample
Selected Reaction Monitoring Market Segment Analysis – By Application:
Based
on Application, Selected Reaction
Monitoring Market is segmented into Biological Marker Assessment, MRM-MS
Quality Control - Platform Performance and Workflow Performance. Biological Marker
Assessment accounted for the largest revenue market share in 2020 owing to increased R&D support for pharma and biotech firms,
increased number of CROs and low cost of clinical trials in developing
countries, high cancer incidence, and new research initiatives. Biological
Markers are commonly used to diagnose and treat a variety of diseases like targeted proteomics.
The levels of Biological Markers in the body change as a result of drug
administration. Selected Biological Marker research assists physicians in
making critical decisions regarding a patient's condition, disease level,
treatment plan, and prognosis.
Selected Reaction
Monitoring Industry expansion is growing owing towards the rising global
prevalence of cancer, the use of cancer Biological Markers has risen
dramatically in recent years, creating opportunities to improve cancer patient
care by improving diagnosis and treatment effectiveness. MRM-MS Quality Control segment is anticipated
to grow with the fastest CAGR of 5.8% in the forecast period 2021-2026. The fastest
growth of the segment is owing to Selectedxed mass spectrometry (MS) using
selected reaction monitoring for targeted proteomics, bottom-up quantification
of protein Biological Markers. For instance, The PeptiQuantTM Plus Quality
Control kit line is a set of simple-to-use kits for quality control in
quantitative MRM-MS proteomics workflows or routine instrument quality
assurance.
Selected Reaction Monitoring Market Segment Analysis – By End User:
Based on End User, Selected Reaction Monitoring Market is segmented into Hospitals, Diagnostic Centres and Research Institutes. Hospital accounted for the largest revenue market share in 2020. Improving healthcare facilities, medical diagnostic, and pathological laboratories, private-public ventures, and the health insurance sector are likely to drive this development. Furthermore, with the increase of societal health consciousness, targeted proteomics and the increasing burden of cardiovascular diseases the demand for Selected Reaction Monitoring Industry is increasing.
Diagnostic
Centres segment is anticipated to grow with the fastest CAGR of 5.5%
during the forecast period 2021-2026. The demand for medical services is
expected to expand as knowledge and affordability rise, as is already the case
in many developed countries, where healthcare services contribute significantly
to GDP growth, thereby, expanding the Selected Reaction Monitoring Market.
Selected Reaction Monitoring Market Segment Analysis - By Geography:
Based on Geography, North America Selected Reaction Monitoring Market
accounted for the 42% revenue share in 2020 owing towards the presence of
several key players in the region. In the United States, cardiovascular
diseases appear to be the leading cause of morbidity and mortality. Companies
in this market are concentrating their efforts on discovering cardiac Biological
Markers in order to gain a better understanding of the pathophysiology of these
diseases. Most major players are undertaking a range of strategic strategies,
such as mergers and acquisitions, new product growth, and public awareness
campaigns, in order to retain or boost their Biological Marker market position.
For instance, Roche Diagnostics Biological Marker assay for bladder cancer
was approved by the Food and Drug Administration (FDA) in May 2017. By using
both tumor cell staining and immune cell staining and scoring inside the tumor,
the assay test will determine a patient's PD-L1 status aiding towards the Selected
Reaction Monitoring Industry. Asia-Pacific is predicted to be the fastest growing
region during the forecast period 2021- 2026. The presence of leading Biological
Marker players in the region, strategic initiatives for product co-development,
and increased R&D investment in developing countries are some of the
factors driving growth. The cost of clinical trials in developing economies is
lower than in developed economies, which is expected to have a positive impact
on the expansion.
Selected Reaction Monitoring Market Drivers
The Increasing Diagnostic Applications:
Selected Reaction Monitoring play an important role in personalized medicine, with applications such as
diagnosis, prognosis, and therapy collection. Owing to many shortcomings of
conventional diagnosis and treatment methods, personalized medicine has gained
popularity over time. From cancer to immunological disorders, several fields of
medicine are shifting toward personalized care for specific patients based on
their genetic signatures and clinical characteristics. Companion diagnostics
and Biological Markers have become increasingly significant in medical
practice, resulting in better diagnosis, care, and monitoring in a variety of
disease areas like targeted proteomics. It can be used to recognize patients
who are likely to react well to certain medications or treatments. These tests
are often used in combination with a particular medication has benefited the
global Selected Reaction Monitoring Market's growth trajectory. Furthermore,
the rising disease burden, together with the broader population in these
geographic segments, is a key factor in higher growth expectations in these
areas. In addition, the increasing number of hospitals globally presents
significant opportunities for Selected Reaction Monitoring manufacturers.
Selected Reaction Monitoring Market Challenges
High Initial Capital Expenditures And A Low Cost-Benefit Ratio:
Selected Reaction Monitoring discovery, growth, and
validation necessitate major financial investments. This stifles the market's
and related markets' growth, such as diagnostics and personalized medicines.
The current ability to validate candidate Biological Markers greatly outpaces
its discovery. The customized medicines industry faces a significant challenge
in this regard. Diagnostics manufacturers also face major financial challenges
as a result of the high drug attrition rate in clinical trials. Strict
regulatory requirements and a shortage of standardization resources in some
developed and developing countries are two major factors that are expected hinder
Selected Reaction Monitoring Market growth. Clinical trials and meeting strict
regulatory criteria necessitate significant investments, which not only limit
small companies' ability to produce Biological Markers but also stifle
innovation. As a result, business growth is hampered by both high capital costs
and a poor cost-benefit ratio.
Selected Reaction Monitoring Market - Landscape:
The Selected Reaction Monitoring Market's main strategies include
product releases, mergers and acquisitions, joint ventures, and regional
expansion. Selected Reaction Monitoring
Market top 10 companies are MRM Proteomics, Sigma Aldrich, Luminex
Corporation, Becton, Dickinson and Company, Alphalyse, Proteomics, Illumina,
Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V. and Thermo Fisher Scientific.
Major players are Becton, Dickinson and Company, Alphalyse, Proteomics, Illumina,
Inc. and Others.
Acquisitions/Product Launches:
- In October 2020, Becton, Dickinson and Company acquired San Diego biomedical business CareFusion for $12.2 billion. By addressing unmet needs in hospitals, hospital pharmacies, and alternative sites of treatment, the acquisition would enhance patient care efficiency and lower health-care costs by increasing efficiencies and reducing drug administration errors.
Related Reports
Report Code: HCR 0194
Biomarkers Market -
Forecast(2021 - 2026)
Report Code: HCR 0059
For more Lifesciences and Healthcare Market reports, please click here
1. Selected Reaction Monitoring Market - Overview
1.1 Definitions and Scope
2. Selected Reaction Monitoring Market - Executive Summary
2.1 Market Revenue, Market Size and Key Trends
2.2 Key trends by Application
2.3 Key trends by End User
2.4 Key trends by Geography
3. Selected Reaction Monitoring Market - Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis– Key Companies
3.3 Market Share Analysis
3.4 Patent Analysis
3.5 Pricing Analysis- Average Selling Price
4. Selected Reaction Monitoring Market - Startup Companies Scenario Premium
4.1 Key Startup Company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Venture Capital and Funding Scenario
5. Selected Reaction Monitoring Market – Industry Market Entry Scenario Premium Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing Business Index
5.3 Case Studies of Successful Ventures
6. Selected Reaction Monitoring Market - Forces
6.1 Market Drivers
6.2 Market Constraints/Challenges
6.3 Porters Five Force Model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Selected Reaction Monitoring Market – Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle
8. Selected Reaction Monitoring Market – By Type (Market Size –$Million/$Billion)
8.1 Custom MRM Assays
8.2 Human Discovery Assay
8.3 Human Cardiovascular MRM Assay
8.4 Human Cancer MRM Assay
9. Selected Reaction Monitoring Market – By Application (Market Size –$Million/$Billion)
9.1 Biomarker Assessment
9.2 MRM-MS Quality Control
9.2.1 Platform Performance
9.2.2 Workflow Performance
10. Selected Reaction Monitoring Market – By End User (Market Size –$Million/$Billion)
10.1 Hospitals
10.2 Diagnostic Centers
10.3 Research Institutes
11. Selected Reaction Monitoring Market - By Geography (Market Size –$Million/$Billion)
11.1 North America
11.1.1 U.S.
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 U.K.
11.2.2 Germany
11.2.3 France
11.2.4 Italy
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Asia-Pacific
11.3.1 China
11.3.2 India
11.3.3 Japan
11.3.4 South Korea
11.3.5 Australia & New Zealand
11.3.6 Rest of Asia-Pacific
11.4 South America
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Rest of South America
11.5 Rest of the World
11.5.1 Middle East
11.5.2 Africa
12. Selected Reaction Monitoring Market - Entropy
13. Selected Reaction Monitoring Market – Industry/Segment Competition Landscape Premium
13.1 Market Share Analysis
13.1.1 Global Market Share – Key Companies
13.1.2 Market Share by Region – Key companies
13.1.3 Market Share by Countries – Key Companies
13.1.4 Best Practices for Companies
14. Selected Reaction Monitoring Market – Key Company List by Country Premium Premium
15. Selected Reaction Monitoring Market Company Analysis
15.1 Company 1
15.2 Company 2
15.3 Company 3
15.4 Company 4
15.5 Company 5
15.6 Company 6
15.7 Company 7
15.8 Company 8
15.9 Company 9
15.10 Company 10
"*Financials for private companies would be provided on a best efforts basi
LIST OF TABLES
1.Global SELECTED REACTION MONITORING MARKET, BY ASSAY TYPE Market 2023-2030 ($M)1.1 CUSTOM ASSAY Market 2023-2030 ($M) - Global Industry Research
1.2 HUMAN DISCOVERY ASSAY Market 2023-2030 ($M) - Global Industry Research
1.3 HUMAN CANCER ASSAY Market 2023-2030 ($M) - Global Industry Research
1.4 HUMAN CARDIOVASCULAR ASSAY Market 2023-2030 ($M) - Global Industry Research
2.Global SELECTED REACTION MONITORING MARKET, BY END USE Market 2023-2030 ($M)
2.1 HOSPITALS Market 2023-2030 ($M) - Global Industry Research
2.2 DIAGNOSTIC CENTRES Market 2023-2030 ($M) - Global Industry Research
2.3 RESEARCH INSTITUTES Market 2023-2030 ($M) - Global Industry Research
3.Global SELECTED REACTION MONITORING MARKET, BY ASSAY TYPE Market 2023-2030 (Volume/Units)
3.1 CUSTOM ASSAY Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 HUMAN DISCOVERY ASSAY Market 2023-2030 (Volume/Units) - Global Industry Research
3.3 HUMAN CANCER ASSAY Market 2023-2030 (Volume/Units) - Global Industry Research
3.4 HUMAN CARDIOVASCULAR ASSAY Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global SELECTED REACTION MONITORING MARKET, BY END USE Market 2023-2030 (Volume/Units)
4.1 HOSPITALS Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 DIAGNOSTIC CENTRES Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 RESEARCH INSTITUTES Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America SELECTED REACTION MONITORING MARKET, BY ASSAY TYPE Market 2023-2030 ($M)
5.1 CUSTOM ASSAY Market 2023-2030 ($M) - Regional Industry Research
5.2 HUMAN DISCOVERY ASSAY Market 2023-2030 ($M) - Regional Industry Research
5.3 HUMAN CANCER ASSAY Market 2023-2030 ($M) - Regional Industry Research
5.4 HUMAN CARDIOVASCULAR ASSAY Market 2023-2030 ($M) - Regional Industry Research
6.North America SELECTED REACTION MONITORING MARKET, BY END USE Market 2023-2030 ($M)
6.1 HOSPITALS Market 2023-2030 ($M) - Regional Industry Research
6.2 DIAGNOSTIC CENTRES Market 2023-2030 ($M) - Regional Industry Research
6.3 RESEARCH INSTITUTES Market 2023-2030 ($M) - Regional Industry Research
7.South America SELECTED REACTION MONITORING MARKET, BY ASSAY TYPE Market 2023-2030 ($M)
7.1 CUSTOM ASSAY Market 2023-2030 ($M) - Regional Industry Research
7.2 HUMAN DISCOVERY ASSAY Market 2023-2030 ($M) - Regional Industry Research
7.3 HUMAN CANCER ASSAY Market 2023-2030 ($M) - Regional Industry Research
7.4 HUMAN CARDIOVASCULAR ASSAY Market 2023-2030 ($M) - Regional Industry Research
8.South America SELECTED REACTION MONITORING MARKET, BY END USE Market 2023-2030 ($M)
8.1 HOSPITALS Market 2023-2030 ($M) - Regional Industry Research
8.2 DIAGNOSTIC CENTRES Market 2023-2030 ($M) - Regional Industry Research
8.3 RESEARCH INSTITUTES Market 2023-2030 ($M) - Regional Industry Research
9.Europe SELECTED REACTION MONITORING MARKET, BY ASSAY TYPE Market 2023-2030 ($M)
9.1 CUSTOM ASSAY Market 2023-2030 ($M) - Regional Industry Research
9.2 HUMAN DISCOVERY ASSAY Market 2023-2030 ($M) - Regional Industry Research
9.3 HUMAN CANCER ASSAY Market 2023-2030 ($M) - Regional Industry Research
9.4 HUMAN CARDIOVASCULAR ASSAY Market 2023-2030 ($M) - Regional Industry Research
10.Europe SELECTED REACTION MONITORING MARKET, BY END USE Market 2023-2030 ($M)
10.1 HOSPITALS Market 2023-2030 ($M) - Regional Industry Research
10.2 DIAGNOSTIC CENTRES Market 2023-2030 ($M) - Regional Industry Research
10.3 RESEARCH INSTITUTES Market 2023-2030 ($M) - Regional Industry Research
11.APAC SELECTED REACTION MONITORING MARKET, BY ASSAY TYPE Market 2023-2030 ($M)
11.1 CUSTOM ASSAY Market 2023-2030 ($M) - Regional Industry Research
11.2 HUMAN DISCOVERY ASSAY Market 2023-2030 ($M) - Regional Industry Research
11.3 HUMAN CANCER ASSAY Market 2023-2030 ($M) - Regional Industry Research
11.4 HUMAN CARDIOVASCULAR ASSAY Market 2023-2030 ($M) - Regional Industry Research
12.APAC SELECTED REACTION MONITORING MARKET, BY END USE Market 2023-2030 ($M)
12.1 HOSPITALS Market 2023-2030 ($M) - Regional Industry Research
12.2 DIAGNOSTIC CENTRES Market 2023-2030 ($M) - Regional Industry Research
12.3 RESEARCH INSTITUTES Market 2023-2030 ($M) - Regional Industry Research
13.MENA SELECTED REACTION MONITORING MARKET, BY ASSAY TYPE Market 2023-2030 ($M)
13.1 CUSTOM ASSAY Market 2023-2030 ($M) - Regional Industry Research
13.2 HUMAN DISCOVERY ASSAY Market 2023-2030 ($M) - Regional Industry Research
13.3 HUMAN CANCER ASSAY Market 2023-2030 ($M) - Regional Industry Research
13.4 HUMAN CARDIOVASCULAR ASSAY Market 2023-2030 ($M) - Regional Industry Research
14.MENA SELECTED REACTION MONITORING MARKET, BY END USE Market 2023-2030 ($M)
14.1 HOSPITALS Market 2023-2030 ($M) - Regional Industry Research
14.2 DIAGNOSTIC CENTRES Market 2023-2030 ($M) - Regional Industry Research
14.3 RESEARCH INSTITUTES Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)2.Canada Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
3.Mexico Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
4.Brazil Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
5.Argentina Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
6.Peru Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
7.Colombia Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
8.Chile Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
9.Rest of South America Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
10.UK Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
11.Germany Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
12.France Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
13.Italy Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
14.Spain Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
15.Rest of Europe Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
16.China Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
17.India Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
18.Japan Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
19.South Korea Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
20.South Africa Selected Reaction Monitoring Market Revenue, 2023-2030 ($M)
21.North America Selected Reaction Monitoring By Application
22.South America Selected Reaction Monitoring By Application
23.Europe Selected Reaction Monitoring By Application
24.APAC Selected Reaction Monitoring By Application
25.MENA Selected Reaction Monitoring By Application
26.SIGMA ALDRICH, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.THERMO FISHER SCIENTIFIC, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.ALPHALYSE, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.PROTEOMICS, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.LUMINEX CORPORATION, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.BECTON, DICKINSON AND COMPANY, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.ILLUMINA, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.BIO-RAD LABORATORIES, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.QIAGEN N.V., Sales /Revenue, 2015-2018 ($Mn/$Bn)